⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Molecular Screening for Lynch Syndrome in Denmark

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Molecular Screening for Lynch Syndrome in Denmark

Official Title: Molecular Screening for Lynch Syndrome in Denmark

Study ID: NCT01845753

Interventions

Observation

Study Description

Brief Summary: A clinically applicably strategy for molecular screening for Lynch Syndrome is being implemented in Denmark. Based on sequential analysis with immunohistochemistry and methylation analysis, patients with possible hereditary colorectal cancer are identified. These patients are offered genetic risk assessment and counselling. The study hypothesis is that molecular screening will identify more patients with Lynch Syndrome than the family history alone. Prospective data collection is performed using established clinical databases.

Detailed Description:

Keywords

Eligibility

Minimum Age:

Eligible Ages: CHILD, ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Department of Pathology, Aalborg, , Denmark

Department of Clinical Genetics, Aarhus, , Denmark

Department of Pathology, Aarhus, , Denmark

Department of Pathology, Esbjerg, , Denmark

Department of Pathology, Hjørring, , Denmark

Department of Clinical Genetics, Odense, , Denmark

Department of Pathology, Odense, , Denmark

Department of Pathology, Sønderborg, , Denmark

Vejle Hospital, Vejle, , Denmark

Department of Clinical Genetics, Vejle, , Denmark

Department of Pathology, Vejle, , Denmark

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: